World's Best Scientists 2026 revealed!
Award Badge
Chemistry
New Zealand
2026

D-Index & Metrics

Chemistry

D-Index
71
Citations
14708
World Ranking
5692
National Ranking
8

William R. Wilson publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where William R. Wilson sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 644 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 253 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 321 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

William R. Wilson D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where William R. Wilson sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 776 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 647 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 71 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Chemistry in New Zealand Leader Award
  • 2025 - Research.com Chemistry in New Zealand Leader Award
  • 2022 - Research.com Chemistry in New Zealand Leader Award

Overview

William R. Wilson is affiliated with the University of Auckland in New Zealand. Their research spans several areas within the broader fields of biochemistry, genetics, molecular biology, and medicine.

The scientist's work concentrates on molecular biology, cancer research, oncology, genetics, and pulmonary and respiratory medicine as key subfields of study. Their main topics of research include:

  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Cancer Research and Treatments
  • Nanoplatforms for cancer theranostics
  • CAR-T cell therapy research
  • Autophagy in Disease and Therapy

Wilson has published frequently in venues such as:

  • Journal of Crohn's and Colitis
  • Cancer Research
  • Cancer Gene Therapy
  • European Journal of Cancer
  • Nature Reviews Clinical Oncology

Recent papers authored or co-authored by William R. Wilson include:

  • Therapeutic targeting of the hypoxic tumour microenvironment, 2021, Nature Reviews Clinical Oncology
  • Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648, 2021, Radiotherapy and Oncology
  • Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect, 2022, Pharmaceutical Research
  • Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit, 2021, Cancer Gene Therapy
  • Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity, 2020, Molecules

Frequent collaborators with whom Wilson has authored multiple papers include:

  • Stephen M. F. Jamieson
  • Michael P. Hay
  • Cho Rong Hong
  • Way W. Wong
  • Benjamin D. Dickson

Best Publications

  • Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.

    Manju Kanamala;William R. Wilson;Mimi Yang;Brian D. Palmer

  • Therapeutic targeting of the hypoxic tumour microenvironment.

    Dean C Singleton;Andrew Macann;William R Wilson

  • A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells

    Graeme J. Finlay;Bruce C. Baguley;William R. Wilson

  • Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.

    David C. Ware;Brian D. Palmer;William R. Wilson;William A. Denny

  • DNA-Directed Alkylating Agents. 6. Synthesis and Antitumor Activity of DNA Minor Groove-Targeted Aniline Mustard Analogs of Pibenzimol (Hoechst 33258)

    Gravatt Gl;Baguley Bc;Wilson Wr;Denny Wa

  • Blood Flow Failure as a Major Determinant in the Antitumor Action of Flavone Acetic Acid

    L. Jonathan Zwi;Bruce C. Baguley;John B. Gavin;William R. Wilson

  • Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells.

    William A. Denny;William R. Wilson

  • Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.

    Brian D. Palmer;William R. Wilson;Susan M. Pullen;William A. Denny

  • Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

    C J Lash;A E Li;M Rutland;B C Baguley

  • Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors

    Kevin O. Hicks;Bronwyn G. Siim;Jagdish K. Jaiswal;Frederik B. Pruijn

  • Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.

    Kevin O Hicks;Frederik B Pruijn;Joanna R Sturman;William A Denny

  • Structure−Activity Relationships of 1,2,4-Benzotriazine 1,4-Dioxides as Hypoxia-Selective Analogues of Tirapazamine

    Michael P Hay;Swarna A Gamage;Mary S Kovacs;Frederik B Pruijn

  • Recent developments in the design of bioreductive drugs.

    W. A. Denny;W. R. Wilson;M. P. Hay

  • A 2-nitroimidazole carbamate prodrug of 5-amino-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydro-3H-benz[e]indole (amino-seco-CBI-TMI) for use with ADEPT and GDEPT

    Michael P. Hay;Bridget M. Sykes;William A. Denny;William R. Wilson

  • Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids.

    William R. Wilson;Bruce C. Baguley;Laurence P. G. Wakelin;Michael J. Waring

  • Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

    Bronwyn G. Siim;Alan E. Lee;Sahar Shalal-Zwain;Frederik B. Pruijn

  • Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.

    G.M. Anlezark;R.G. Melton;R.F. Sherwood;W.R. Wilson

  • Unsymmetrical DNA Cross-Linking Agents: Combination of the CBI and PBD Pharmacophores

    Moana Tercel;Stephen M Stribbling;Hilary Sheppard;Bronwyn G Siim

  • Combination therapy for cancer

    William R. Wilson

  • Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

    William A Denny;William R Wilson

  • DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.

    T. A. Gourdie;K. K. Valu;G. L. Gravatt;T. J. Boritzki

  • Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954

    GA Prosser;JN Copp;SP Syddall;EM Williams

Frequent Co-Authors

William A. Denny
William A. Denny University of Auckland
Bruce C. Baguley
Bruce C. Baguley University of Auckland
Brian D. Palmer
Brian D. Palmer University of Auckland
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
J. Martin Brown
J. Martin Brown Stanford University
Cristin G. Print
Cristin G. Print University of Auckland
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Bradly G. Wouters
Bradly G. Wouters Princess Margaret Cancer Centre
Deborah A. Thomas
Deborah A. Thomas The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, exploring related fields through online degrees can open diverse career opportunities. Fields such as Criminal Justice offer a different perspective on science and law enforcement, with many affordable programs available. Understanding the criminal justice degree cost is important for making informed decisions about your education budget.

Online education also provides flexible options like criminal justice associate programs online, which can complement a background in Chemistry for careers that intersect with forensic science or regulatory compliance.

Alternatively, pursuing paralegal degrees related to intellectual property or patent law can be rewarding. Careers in this domain often offer competitive salaries, as detailed in the overview of paralegal salary expectations.

For those interested in the commercial side of Chemistry, becoming a pharmaceutical sales representative combines scientific knowledge with business skills. Understanding how much do pharmaceutical sales reps make can help you evaluate this career’s financial potential and growth prospects.

Best Scientists Citing William R. Wilson

Trending Scientists

Recently Published Articles